2022-RA-1556-ESGO Uterine cervix clear cell adenocarcinoma: Tunisian experience in post Diethylboestrol era | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Cervical cancer

2022-RA-1556-ESGO Uterine cervix clear cell adenocarcinoma: Tunisian experience in post Diethylboestrol era

Free

Online download statistics by month:

Online download statistics by month: October 2022 to September 2024

	Abstract	Full	Pdf
Oct 2022	4	0	0
Nov 2022	34	0	3
Dec 2022	51	0	11
Jan 2023	14	0	2
Feb 2023	8	0	1
Mar 2023	6	0	0
Apr 2023	11	0	0
May 2023	14	0	5
Jun 2023	2	0	0
Jul 2023	16	0	8
Aug 2023	8	0	8
Sep 2023	4	0	1
Oct 2023	18	0	1
Nov 2023	10	0	1
Dec 2023	31	0	3
Jan 2024	14	0	3
Feb 2024	6	0	1
Mar 2024	12	0	3
Apr 2024	8	0	2
May 2024	10	0	2
Jun 2024	12	0	2
Jul 2024	2	0	2
Aug 2024	2	0	3
Sep 2024	13	0	1
Total	310	0	63